放疗联合ADT治疗前列腺癌的共识与争议演示文稿.ppt

Company Logo WPRT vs PORT：RTOG 9413 1323 entered 644 WPRT + HT 648 PORT + HT 322 WPRT + NCHT T1C-4 N0/X M0 LN risk15% Goserelin 3.6 mg +Flutamide 250 mg WPRT 50.4+19.8GY; PORT 70.2GY 322 WPRT + AHT 323 PORT + NCHT 323 PORT + AHT M. Roach III,et al. J Clin Oncol . 2003, 21:1904-1911 4m NCHT Company Logo WPRT : 提高4y-PFS WPRT 4y-PFS 54.2% PORT 4y-PFS 47.0% J Clin Oncol . 2003, 21:1904-1911 Company Logo Pascal Pommier, et al. J Clin Oncol. 2007, 25:5366-5373 WPRT vs PORT： GETUG-01 T1b-3 N0/X M0 WPRT 46+20-24GY; PORT 66-70GY 4-8m NCHT Company Logo WPRT 与 PORT ：OS无显著差异 J Clin Oncol.